- Home
- OPXS vs PLRX Comparison
OPXS vs PLRX Comparison
Compare OPXS & PLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPXS
- PLRX
- Stock Information
- Founded
- OPXS 1987
- PLRX 2015
- Country
- OPXS United States
- PLRX United States
- Employees
- OPXS N/A
- PLRX N/A
- Industry
- OPXS Electronic Components
- PLRX Biotechnology: Pharmaceutical Preparations
- Sector
- OPXS Technology
- PLRX Health Care
- Exchange
- OPXS Nasdaq
- PLRX Nasdaq
- Market Cap
- OPXS 89.0M
- PLRX 93.3M
- IPO Year
- OPXS N/A
- PLRX 2020
- Fundamental
- Price
- OPXS $13.72
- PLRX $1.57
- Analyst Decision
- OPXS
- PLRX Hold
- Analyst Count
- OPXS 0
- PLRX 11
- Target Price
- OPXS N/A
- PLRX $3.79
- AVG Volume (30 Days)
- OPXS 38.8K
- PLRX 707.4K
- Earning Date
- OPXS 12-18-2025
- PLRX 11-06-2025
- Dividend Yield
- OPXS N/A
- PLRX N/A
- EPS Growth
- OPXS 23.32
- PLRX N/A
- EPS
- OPXS 0.75
- PLRX N/A
- Revenue
- OPXS $39,481,000.00
- PLRX N/A
- Revenue This Year
- OPXS N/A
- PLRX N/A
- Revenue Next Year
- OPXS N/A
- PLRX N/A
- P/E Ratio
- OPXS $18.09
- PLRX N/A
- Revenue Growth
- OPXS 21.00
- PLRX N/A
- 52 Week Low
- OPXS $5.36
- PLRX $1.10
- 52 Week High
- OPXS $17.76
- PLRX $15.80
- Technical
- Relative Strength Index (RSI)
- OPXS 43.35
- PLRX 46.13
- Support Level
- OPXS $12.50
- PLRX $1.48
- Resistance Level
- OPXS $14.13
- PLRX $1.82
- Average True Range (ATR)
- OPXS 1.01
- PLRX 0.12
- MACD
- OPXS -0.25
- PLRX -0.02
- Stochastic Oscillator
- OPXS 29.37
- PLRX 32.88
About OPXS Optex Systems Holdings Inc.
Optex Systems Holdings Inc manufactures optical sighting systems and assemblies for the U.S. Department of Defense, foreign military applications, and commercial markets. Its products are installed on a variety of United States military land vehicles, such as the Abrams and Bradley fighting vehicles, and light armored and security vehicles, and have been selected for installation on the Stryker family of vehicles. The company's operating segment includes Optex Systems Richardson and Applied Optics Center Dallas and others. It generates maximum revenue from the Optex Systems Richardson segment. Some of its products include M17 Day/Thermal Periscope; DDAN / M36 Sights; Laser Protected Periscopes; Muzzle Reference Sensor and others.
About PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.